Group One Trading’s Treace Medical Concepts TMCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$60.3K Buy
15,147
+9,208
+155% +$25.3K ﹤0.01% 5254
2026
Q1
$7.96K Buy
5,939
+5,294
+821% +$10.6K ﹤0.01% 6490
2025
Q4
$1.58K Buy
+645
New +$2.8K ﹤0.01% 7621
2025
Q2
Sell
-17,917
Closed -$117K 8666
2025
Q1
$150K Sell
17,917
-57,173
-76% -$514K ﹤0.01% 4249
2024
Q4
$559K Sell
75,090
-3,845
-5% -$25.7K ﹤0.01% 3081
2024
Q3
$458K Sell
78,935
-24,257
-24% -$156K ﹤0.01% 2915
2024
Q2
$686K Sell
103,192
-18,968
-16% -$153K ﹤0.01% 2301
2024
Q1
$1.59M Sell
122,160
-4,396
-3% -$58.6K 0.01% 1681
2023
Q4
$1.61M Buy
+126,556
New +$1.28M ﹤0.01% 2046

Other funds holding TMCI

Group One Trading's TMCI Position: Q2 2026 in Review

Group One Trading increased its Treace Medical Concepts (TMCI) stake by 155% in Q2 2026, buying an estimated $25.3K and bringing the position to 15,147 shares worth $60.3K. The position accounts for ﹤0.01% of the portfolio, ranked #5254.

Group One Trading first reported a position in TMCI in Q4 2023 and has held it in 9 quarters since. The position peaked at $1.61M in Q4 2023. 116 funds tracked by Wall St. Rank hold TMCI as of Q2 2026.

  • Group One Trading held 15,147 shares of Treace Medical Concepts worth $60.3K as of Q2 2026.
  • Group One Trading bought 9,208 Treace Medical Concepts shares in Q2 2026, an estimated $25.3K.
  • Treace Medical Concepts made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #5254 holding.
  • Group One Trading first reported a position in Treace Medical Concepts in Q4 2023 and has held it in 9 quarters since.
  • Group One Trading's Treace Medical Concepts position peaked at $1.61M in Q4 2023.
  • 116 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.